CSF3 and hematopoietic and lymphoid cell neoplasm: The most widely used agent is the granulocyte colony-stimulating factor (G-CSF) filgrastim, which is usually given by subcutaneous injection in conjunction with chemotherapy in hematological cancer patients [13, 15].